Luciana Borio

Luciana Borio

Directeur/Membre du Conseil chez EAGLE PHARMACEUTICALS, INC.

Fortune : 584 373 $ au 31/05/2024

53 ans
Health Technology
Consumer Services
Commercial Services

Profil

Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners.
In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs.
Dr. Borio is a specialist in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.
Prior to joining ARCH, she was a senior vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to deliver innovative technology solutions to support the missions of the U.S.
Intelligence Community.
Past positions include serving as a member of President Biden’s transition COVID-19 Advisory Board and Director for Medical and Biodefense Preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America’s influenza vaccines.
Prior to that, she was the Acting Chief Scientist of the U.S.
Food and Drug Administration (2015-2017) and the Assistant Commissioner for Counterterrorism Policy of the FDA (2010-2017).
Dr. Borio is an adjunct Assistant Professor of Medicine at Johns Hopkins University (2003-present), where she continues to practice medicine part-time.
She is also a senior fellow for global health at the Council on Foreign Relations.
Dr. Borio obtained her M.D.
from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2024 3 298 ( 0,00% ) 584 373 $ 31/05/2024
31/03/2023 0 ( -.--% ) - $ 31/05/2024

Postes actifs de Luciana Borio

SociétésPosteDébut
EAGLE PHARMACEUTICALS, INC. Directeur/Membre du Conseil 28/04/2021
INSULET CORPORATION Directeur/Membre du Conseil 18/10/2021
Directeur/Membre du Conseil 25/10/2021
Private Equity Investor 01/12/2021
Directeur/Membre du Conseil -
Tous les postes actifs de Luciana Borio

Anciens postes connus de Luciana Borio

SociétésPosteFin
Corporate Officer/Principal 01/01/2020
National Security Council Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/01/2017
Corporate Officer/Principal 01/10/2008
Voir l'expérience en détail de Luciana Borio

Formation de Luciana Borio

George Washington University School of Medicine & Health Doctorate Degree
George Washington University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Luciana Borio

Relations

100 +

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
EAGLE PHARMACEUTICALS, INC.

Health Technology

INSULET CORPORATION

Health Technology

Entreprise privées7

Commercial Services

Finance

Finance

Technology Services

National Security Council

Commercial Services

Government

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Luciana Borio